双侧下颌神经阻滞改善下颌截骨术后镇痛并减少吗啡用量:前瞻性随机双盲安慰剂对照临床试验
这项单中心前瞻性随机双盲安慰剂对照研究纳入107例下颌手术患者(75例计划截骨和32例下颌骨折),随机接受双侧V3阻滞用0.75%罗哌卡因(阻滞组n=50)或安慰剂(安慰剂组n=57),两组均提供术后多模式镇痛。主要结局24小时累积吗啡消耗量阻滞组显著低于安慰剂组(中位数8.0 mg vs 12.0 mg,p=0.03),严重疼痛发生率也显著降低(4.0% vs 22.8%,p<0.01),但PONV发生率无影响。
要点
- 双侧V3阻滞可减少下颌截骨术后24小时吗啡累积消耗量。
- 双侧V3阻滞降低术后24小时严重疼痛发生率。
- 双侧V3阻滞对术后恶心呕吐发生率无影响。
核心结论
- 双侧下颌神经(V3)阻滞用于下颌截骨术是一种有效的阿片类药物节约措施,可改善术后24小时镇痛且不影响PONV发生率。
研究设计与样本
- 单中心、前瞻性、随机、双盲、安慰剂对照临床试验,纳入107例下颌手术患者(75例计划截骨和32例下颌骨折),随机分为阻滞组(n=50,0.75%罗哌卡因)和安慰剂组(n=57),按意向性治疗分析。
主要发现
- 24小时累积吗啡消耗量阻滞组中位数8.0 mg(IQR 2.0-21.3),安慰剂组12.0 mg(IQR 8.0-22.0),p=0.03。
- 24小时随访期间严重疼痛发生率阻滞组4.0%,安慰剂组22.8%,p<0.01。
- 下颌阻滞对术后恶心呕吐(PONV)发生率无影响。
临床怎么用
- 对于下颌截骨术患者,可考虑实施双侧V3阻滞(0.75%罗哌卡因)作为术后多模式镇痛的一部分,以减少阿片类药物用量并降低严重疼痛发生率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The sensory innervation of the lower jaw mainly depends on the third root of the trigeminal nerve, the mandibular nerve (V3). The aim of this single-center, prospective, randomized, double-blind, placebo-controlled study was to evaluate the effectiveness of bilateral V3 block for postoperative analgesia management in mandibular osteotomies. METHODS: 107 patients undergoing mandibular surgery (75 scheduled osteotomies and 32 mandible fractures) were randomized in two groups. A bilateral V3 block was performed in each group, either with ropivacaine 0.75% (block group, n=50) or with a placebo (placebo group, n=57). A postoperative multimodal analgesia was equally provided to both groups. The primary outcome was the cumulative morphine consumption at 24 hours. Secondary outcomes were the occurrence of severe pain and the incidence of postoperative nausea and vomiting (PONV) in the first 24 hours. Data were analyzed on an intention-to-treat basis. RESULTS: The cumulative morphine consumption at 24 hours was significantly lower in the block group (median 8.0 mg (IQR 2.0-21.3) vs 12.0 mg (IQR 8.0-22.0), p=0.03), as well as the incidence of severe pain during the 24 hours of follow-up (4.0% vs 22.8%, p<0.01). The mandibular block had no impact on the incidence of PONV. CONCLUSION: Bilateral V3 block for mandibular osteotomies is an effective opioid-sparing procedure. It provided better postoperative analgesia in the first 24 hours, and it did not affect PONV incidence. TRIAL REGISTRATION NUMBER: NCT02618993.
引用
- Bertuit M, Rapido F, Ly H, et al. Bilateral mandibular block improves pain relief and morphine consumption in mandibular osteotomies: a prospective, randomized, double-blind, placebo-controlled clinical trial. Reg Anesth Pain Med. 2021. PMID: 33563767. doi:10.1136/rapm-2020-102417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。